Results
|
|
1481.
|
|
|
|
1482.
|
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia. [electronic resource] by
- Kantarjian, Hagop M
- Martinelli, Giovanni
- Jabbour, Elias J
- Quintás-Cardama, Alfonso
- Ando, Kiyoshi
- Bay, Jacques-Olivier
- Wei, Andrew
- Gröpper, Stefanie
- Papayannidis, Cristina
- Owen, Kate
- Pike, Laura
- Schmitt, Nicola
- Stockman, Paul K
- Giagounidis, Aristoteles
Producer: 20130916
In:
Cancer vol. 119
Availability: No items available.
|
|
|
1483.
|
Biological characterization of TAK-901, an investigational, novel, multitargeted Aurora B kinase inhibitor. [electronic resource] by
- Farrell, Pamela
- Shi, Lihong
- Matuszkiewicz, Jennifer
- Balakrishna, Deepika
- Hoshino, Takashi
- Zhang, Lilly
- Elliott, Sarah
- Fabrey, Robyn
- Lee, Bumsup
- Halkowycz, Petro
- Sang, BiChing
- Ishino, Seigo
- Nomura, Toshiyuki
- Teratani, Mika
- Ohta, Yoshikazu
- Grimshaw, Charles
- Paraselli, Bheema
- Satou, Takashi
- de Jong, Ron
Producer: 20131022
In:
Molecular cancer therapeutics vol. 12
Availability: No items available.
|
|
|
1484.
|
|
|
|
1485.
|
|
|
|
1486.
|
Binding of TPX2 to Aurora A alters substrate and inhibitor interactions. [electronic resource] by
- Anderson, Kelly
- Yang, Jingsong
- Koretke, Kristin
- Nurse, Kelvin
- Calamari, Amy
- Kirkpatrick, Robert B
- Patrick, Denis
- Silva, Domingos
- Tummino, Peter J
- Copeland, Robert A
- Lai, Zhihong
Producer: 20071010
In:
Biochemistry vol. 46
Availability: No items available.
|
|
|
1487.
|
|
|
|
1488.
|
Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression. [electronic resource] by
- Dutta-Simmons, Jui
- Zhang, Yunyu
- Gorgun, Gullu
- Gatt, Moshe
- Mani, Mala
- Hideshima, Teru
- Takada, Kohichi
- Carlson, Nicole E
- Carrasco, Daniel E
- Tai, Yu-Tzu
- Raje, Noopur
- Letai, Anthony G
- Anderson, Kenneth C
- Carrasco, Daniel R
Producer: 20091027
In:
Blood vol. 114
Availability: No items available.
|
|
|
1489.
|
|
|
|
1490.
|
Negative feedback regulation of Aurora-A via phosphorylation of Fas-associated factor-1. [electronic resource] by
- Jang, Moon-Sun
- Sul, Jee-Won
- Choi, Byung-Jung
- Lee, Su-Jin
- Suh, Jee-Hee
- Kim, Nam-Soon
- Kim, Woo Ho
- Lim, Dae-Sik
- Lee, Chang-Woo
- Kim, Eunhee
Producer: 20090122
In:
The Journal of biological chemistry vol. 283
Availability: No items available.
|
|
|
1491.
|
Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. [electronic resource] by
- Wan, Xiang-Bo
- Long, Zi-Jie
- Yan, Min
- Xu, Jie
- Xia, Liang-Ping
- Liu, Li
- Zhao, Yan
- Huang, Xue-Fei
- Wang, Xian-Ren
- Zhu, Xiao-Feng
- Hong, Ming-Huang
- Liu, Quentin
Producer: 20081014
In:
Carcinogenesis vol. 29
Availability: No items available.
|
|
|
1492.
|
|
|
|
1493.
|
|
|
|
1494.
|
|
|
|
1495.
|
|
|
|
1496.
|
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors. [electronic resource] by
- Wang, Shudong
- Midgley, Carol A
- Scaërou, Frederic
- Grabarek, Joanna B
- Griffiths, Gary
- Jackson, Wayne
- Kontopidis, George
- McClue, Steven J
- McInnes, Campbell
- Meades, Christopher
- Mezna, Mokdad
- Plater, Andy
- Stuart, Iain
- Thomas, Mark P
- Wood, Gavin
- Clarke, Rosemary G
- Blake, David G
- Zheleva, Daniella I
- Lane, David P
- Jackson, Robert C
- Glover, David M
- Fischer, Peter M
Producer: 20100701
In:
Journal of medicinal chemistry vol. 53
Availability: No items available.
|
|
|
1497.
|
|
|
|
1498.
|
Aurora B and cyclin B have opposite effects on the timing of cytokinesis abscission in Drosophila germ cells and in vertebrate somatic cells. [electronic resource] by
- Mathieu, Juliette
- Cauvin, Clothilde
- Moch, Clara
- Radford, Sarah J
- Sampaio, Paula
- Perdigoto, Carolina N
- Schweisguth, François
- Bardin, Allison J
- Sunkel, Claudio E
- McKim, Kim
- Echard, Arnaud
- Huynh, Jean-René
Producer: 20131030
In:
Developmental cell vol. 26
Availability: No items available.
|
|
|
1499.
|
|
|
|
1500.
|
|